Concepts (164)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carboxylic Ester Hydrolases | 9 | 2017 | 57 | 2.740 |
Why?
|
| Anoikis | 9 | 2017 | 21 | 2.320 |
Why?
|
| Mitochondrial Proteins | 7 | 2017 | 112 | 2.250 |
Why?
|
| Lung Neoplasms | 5 | 2025 | 479 | 1.830 |
Why?
|
| Cadherins | 3 | 2017 | 102 | 1.430 |
Why?
|
| Co-Repressor Proteins | 5 | 2025 | 18 | 1.310 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2025 | 290 | 1.040 |
Why?
|
| Repressor Proteins | 5 | 2016 | 267 | 0.990 |
Why?
|
| Genetics | 1 | 2025 | 10 | 0.940 |
Why?
|
| Laboratories | 1 | 2025 | 40 | 0.920 |
Why?
|
| Gene Expression Regulation, Neoplastic | 8 | 2025 | 933 | 0.890 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2025 | 199 | 0.870 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2025 | 159 | 0.850 |
Why?
|
| Research | 1 | 2025 | 177 | 0.830 |
Why?
|
| Curriculum | 1 | 2025 | 311 | 0.770 |
Why?
|
| Cell Transformation, Neoplastic | 5 | 2017 | 165 | 0.710 |
Why?
|
| Neoplasm Metastasis | 5 | 2016 | 233 | 0.670 |
Why?
|
| Cyclin D1 | 4 | 2007 | 44 | 0.630 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2017 | 98 | 0.600 |
Why?
|
| Down-Regulation | 6 | 2017 | 452 | 0.480 |
Why?
|
| Cell Line, Tumor | 12 | 2025 | 2598 | 0.460 |
Why?
|
| Apoptosis | 7 | 2013 | 1541 | 0.450 |
Why?
|
| Cell Proliferation | 5 | 2017 | 1420 | 0.390 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2014 | 222 | 0.390 |
Why?
|
| Proto-Oncogene Proteins c-myc | 3 | 2007 | 62 | 0.380 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 287 | 0.370 |
Why?
|
| Serpins | 4 | 2006 | 29 | 0.330 |
Why?
|
| Breast Neoplasms | 6 | 2012 | 1679 | 0.320 |
Why?
|
| Urokinase-Type Plasminogen Activator | 3 | 2006 | 7 | 0.290 |
Why?
|
| Cisplatin | 2 | 2007 | 91 | 0.290 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 167 | 0.270 |
Why?
|
| Protein Kinase C | 1 | 2008 | 124 | 0.270 |
Why?
|
| Humans | 21 | 2025 | 42163 | 0.270 |
Why?
|
| Pancreatic Neoplasms | 2 | 2007 | 206 | 0.270 |
Why?
|
| NF-kappa B | 2 | 2007 | 355 | 0.260 |
Why?
|
| Antigens, CD | 2 | 2017 | 122 | 0.240 |
Why?
|
| Acrylamides | 1 | 2025 | 15 | 0.230 |
Why?
|
| Louisiana | 1 | 2025 | 49 | 0.230 |
Why?
|
| Aniline Compounds | 1 | 2025 | 27 | 0.230 |
Why?
|
| Transfection | 7 | 2012 | 526 | 0.220 |
Why?
|
| Proteins | 3 | 2003 | 383 | 0.220 |
Why?
|
| Pyrimidines | 1 | 2025 | 130 | 0.210 |
Why?
|
| Indoles | 1 | 2025 | 178 | 0.210 |
Why?
|
| Transcription, Genetic | 3 | 2016 | 599 | 0.200 |
Why?
|
| RNA, Small Interfering | 3 | 2014 | 436 | 0.200 |
Why?
|
| Mice | 11 | 2014 | 6490 | 0.200 |
Why?
|
| Universities | 1 | 2025 | 539 | 0.180 |
Why?
|
| Extracellular Matrix | 3 | 2013 | 129 | 0.170 |
Why?
|
| Cell Line | 3 | 2017 | 1416 | 0.170 |
Why?
|
| Mutation | 1 | 2025 | 1169 | 0.160 |
Why?
|
| Antineoplastic Agents | 5 | 2007 | 979 | 0.160 |
Why?
|
| Animals | 12 | 2014 | 16695 | 0.160 |
Why?
|
| Students | 1 | 2025 | 617 | 0.150 |
Why?
|
| Promoter Regions, Genetic | 2 | 2014 | 534 | 0.140 |
Why?
|
| Mitochondria | 2 | 2014 | 516 | 0.140 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 2 | 2008 | 20 | 0.140 |
Why?
|
| Epithelial Cells | 4 | 2013 | 426 | 0.130 |
Why?
|
| Genes, Tumor Suppressor | 4 | 2006 | 61 | 0.130 |
Why?
|
| Genes, X-Linked | 2 | 2007 | 9 | 0.130 |
Why?
|
| Cell Differentiation | 2 | 2017 | 633 | 0.120 |
Why?
|
| Histone Deacetylases | 2 | 2014 | 61 | 0.120 |
Why?
|
| Tumor Burden | 1 | 2014 | 84 | 0.110 |
Why?
|
| Cell Movement | 3 | 2014 | 640 | 0.110 |
Why?
|
| Caspases | 1 | 2014 | 148 | 0.110 |
Why?
|
| Cell Adhesion | 4 | 2008 | 237 | 0.110 |
Why?
|
| Up-Regulation | 1 | 2016 | 534 | 0.100 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 188 | 0.100 |
Why?
|
| Prostatic Neoplasms | 4 | 2006 | 1068 | 0.100 |
Why?
|
| Receptors, Cell Surface | 2 | 2006 | 146 | 0.100 |
Why?
|
| Cell Survival | 2 | 2007 | 934 | 0.100 |
Why?
|
| Neoplasms | 3 | 2011 | 1341 | 0.100 |
Why?
|
| Cell Nucleus | 1 | 2014 | 383 | 0.090 |
Why?
|
| Protein Biosynthesis | 2 | 2003 | 136 | 0.090 |
Why?
|
| Disease Progression | 2 | 2011 | 661 | 0.090 |
Why?
|
| Cell Cycle | 2 | 2005 | 348 | 0.090 |
Why?
|
| Female | 9 | 2014 | 24018 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2008 | 649 | 0.080 |
Why?
|
| MAP Kinase Signaling System | 1 | 2011 | 189 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 1 | 2011 | 686 | 0.080 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 1554 | 0.070 |
Why?
|
| Phosphorylation | 2 | 2008 | 973 | 0.070 |
Why?
|
| Integrins | 1 | 2008 | 54 | 0.070 |
Why?
|
| Cytoplasm | 1 | 2008 | 154 | 0.070 |
Why?
|
| Genes, myc | 1 | 2007 | 30 | 0.070 |
Why?
|
| Nuclear Proteins | 2 | 2007 | 330 | 0.070 |
Why?
|
| Neoplasm Invasiveness | 1 | 2008 | 284 | 0.070 |
Why?
|
| Chromosomes, Human, X | 1 | 2007 | 23 | 0.070 |
Why?
|
| DNA Fragmentation | 1 | 2007 | 95 | 0.070 |
Why?
|
| Membrane Proteins | 2 | 2008 | 548 | 0.060 |
Why?
|
| Recombinant Proteins | 3 | 2006 | 522 | 0.060 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2007 | 69 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 3 | 2003 | 506 | 0.060 |
Why?
|
| Mice, Transgenic | 2 | 2005 | 658 | 0.060 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 2 | 2006 | 10 | 0.060 |
Why?
|
| Pancreatic Elastase | 1 | 2005 | 7 | 0.060 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2005 | 29 | 0.060 |
Why?
|
| Mice, Inbred Strains | 1 | 2005 | 116 | 0.060 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2005 | 54 | 0.060 |
Why?
|
| Culture Media | 1 | 2005 | 96 | 0.060 |
Why?
|
| Deoxycytidine | 1 | 2005 | 35 | 0.060 |
Why?
|
| Models, Biological | 1 | 2008 | 711 | 0.060 |
Why?
|
| Carrier Proteins | 1 | 2007 | 318 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2005 | 152 | 0.060 |
Why?
|
| Lymphatic Vessels | 1 | 2004 | 5 | 0.060 |
Why?
|
| Cell Hypoxia | 1 | 2004 | 57 | 0.050 |
Why?
|
| Peptides, Cyclic | 1 | 2004 | 29 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2005 | 411 | 0.050 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2004 | 62 | 0.050 |
Why?
|
| Osteolysis | 1 | 2003 | 3 | 0.050 |
Why?
|
| Breast | 2 | 2007 | 139 | 0.050 |
Why?
|
| Melanoma | 1 | 2004 | 109 | 0.050 |
Why?
|
| Bone Neoplasms | 1 | 2003 | 48 | 0.050 |
Why?
|
| Cell Membrane | 2 | 2001 | 400 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 1112 | 0.050 |
Why?
|
| Neovascularization, Pathologic | 1 | 2003 | 137 | 0.050 |
Why?
|
| Immunohistochemistry | 3 | 2012 | 928 | 0.050 |
Why?
|
| Mice, SCID | 3 | 2008 | 158 | 0.050 |
Why?
|
| Culture Media, Conditioned | 1 | 2001 | 49 | 0.050 |
Why?
|
| Protein Binding | 1 | 2005 | 1076 | 0.050 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2000 | 10 | 0.040 |
Why?
|
| Cell Growth Processes | 2 | 2012 | 43 | 0.040 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2000 | 71 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2005 | 1804 | 0.040 |
Why?
|
| Phospholipids | 1 | 2000 | 69 | 0.040 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2000 | 110 | 0.040 |
Why?
|
| Antigens, Differentiation | 1 | 1999 | 23 | 0.040 |
Why?
|
| Male | 5 | 2006 | 22779 | 0.040 |
Why?
|
| Claudins | 2 | 2008 | 8 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2000 | 557 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2000 | 722 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2008 | 884 | 0.030 |
Why?
|
| Fibrinolysin | 2 | 2006 | 9 | 0.030 |
Why?
|
| Cell Division | 2 | 2004 | 314 | 0.020 |
Why?
|
| Kinetics | 2 | 2000 | 698 | 0.020 |
Why?
|
| Ataxia | 1 | 2008 | 8 | 0.020 |
Why?
|
| Muscular Dystrophies | 1 | 2008 | 3 | 0.020 |
Why?
|
| Neutropenia | 1 | 2008 | 11 | 0.020 |
Why?
|
| Syndrome | 1 | 2008 | 73 | 0.020 |
Why?
|
| Receptors, CXCR4 | 1 | 2008 | 74 | 0.020 |
Why?
|
| Fetal Development | 1 | 2008 | 34 | 0.020 |
Why?
|
| Retinoblastoma-Binding Protein 7 | 1 | 2007 | 1 | 0.020 |
Why?
|
| Oncogene Proteins | 1 | 2007 | 22 | 0.020 |
Why?
|
| Focal Adhesions | 1 | 2006 | 16 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2005 | 195 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2005 | 206 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2008 | 1010 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 310 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2004 | 98 | 0.010 |
Why?
|
| Collagen Type I | 1 | 2003 | 35 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2007 | 683 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2005 | 239 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 2003 | 129 | 0.010 |
Why?
|
| Cell Death | 1 | 2004 | 277 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2003 | 198 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2004 | 403 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2007 | 1265 | 0.010 |
Why?
|
| Cattle | 1 | 2003 | 505 | 0.010 |
Why?
|
| Helix-Loop-Helix Motifs | 1 | 2000 | 14 | 0.010 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2000 | 25 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 2000 | 107 | 0.010 |
Why?
|
| Fungal Proteins | 1 | 2000 | 143 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2000 | 88 | 0.010 |
Why?
|
| Galectin 3 | 1 | 1999 | 29 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 1848 | 0.010 |
Why?
|